1206910-03-3

Upstream product

• 24691-30-3 3,4-di-chloro-5-methyl-1H-pyrrole-2-carboxylic acid 
• 1206909-99-0 ethyl 2-[(1R,5S,6s)-6-[(tert-butoxycarbonyl)amino]-3-azabicyclo[3.1.0]hex-3-yl]-4-[(3'-chlorobiphenyl-3-yl)methyl]-1,3-thiazole-5-carboxylate 
• 1679-18-1 4-Chlorophenylboronic acid 
• 1206910-00-0 ethyl 2-{(1R,5S,6s)-6-[bis(tert-butoxycarbonyl)amino]-3-azabicyclo[3.1.0]hex-3-yl}-4-(3-bromobenzyl)-1,3-thiazole-5-carboxylate 

Downstream Products

• 1206909-98-9 lithium 4-[(3'-chlorobiphenyl-3-yl)methyl]-2-{[(1R,5S,6s)-6-[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino]-3-azabicyclo[3.1.0]hex-3-yl}-1,3-thiazole-5-carboxylic acid 

Relevant academic research and scientific papers

PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS

The present invention provides DNA Gyrase and/or Topo IV inhibitors of Formula (I), which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonus spp., Acenetobacter spp., Mvraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Mycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Cotynebacterium, Bacillus spp., Enterobactericeae (E. coli, Klebsiella spp., Proteus spp., etc.) or any combination thereof. Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections.

PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS

The present invention provides DNA Gyrase and/or Topo IV inhibitors of formula I, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed by gram positive, gram negative and anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Pseudomonus spp., Acenetobacter spp., Muraxalla spp., Chlamydia spp., Mycoplasma spp., Legionella spp., Mycobacterium spp., Helicobacter, Clostridium spp., Bacteroides spp., Cotyne bacterium, Bacillus spp., Enterobactericeae (E.coli, Klebsiella spp., Proteus spp.,etc.) or any combination thereof Also provided, are processes for preparing compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections